Immunotherapies for COVID-19: lessons learned from sepsisKenneth E. Remy, Lyle L. Moldawer, Scott C. Brakenridge et al.|The Lancet Respiratory Medicine|2020Cited by 165
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)Pierre François Laterre, Richard S. Hotchkiss, Bruno François et al.|JAMA Network Open|2020Cited by 98
Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) diseaseThomas Girard, Jorge Di Paola, Ashley Steed et al.|Journal of Thrombosis and Haemostasis|2023Cited by 30
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19Manu Shankar‐Hari, Richard S. Hotchkiss, Bruno François et al.|JCI Insight|2025Cited by 21
Epstein-Barr Virus Seropositivity, Immune Dysregulation, and Mortality in Pediatric SepsisAditya Sriram, Hyun Jung Park, Kate F. Kernan et al.|JAMA Network Open|2025Cited by 3